Literature DB >> 27312842

Fragile X Premutation Carrier Epidemiology and Symptomatology in Israel-Results from a Tertiary Child Developmental Center.

Lidia V Gabis1,2, Noah Gruber3, Michal Berkenstadt4,5, Shahar Shefer6, Odelia Leon Attia6, Dana Mula6, Yoram Cohen7,5, Shai E Elizur7,5.   

Abstract

Fragile X syndrome (FXS) is the most prevalent known genetically inherited cause for autism and intellectual disability. Premutation state can cause several clinical disorders as well. We aimed to perform a nesting approach to acquire data with regard to first degree relatives of index fragile X cases at the largest child development center in Israel in order to map characteristics of Israeli FXS permutation women carriers. Seventy-nine women were referred due to a related fragile X syndrome patient, mainly an offspring or sibling. General information regarding demographics, ethnicity, and associated medical conditions were collected using interviews and structured questionnaires. Thirteen (17 %) of the women who were referred as "carrier" were proven to be actually full mutation. The mean years of education were 14 (±1.51, range 12-17). Twenty-one women (27 %) originated from Tunisia (mainly from the island of Djerba). Ten women (13 %) reported delivery of their affected offspring beyond 41 gestational weeks. Twenty-two percent of women with premutation reported symptoms consistent with learning difficulties, mainly dyscalculia, and 14 % reported ADHD symptoms. Awareness about clinical disorders of the carriers was existent only in 25 % of the patients. Increased awareness and knowledge dissemination concerning premutation symptomatology and associated medical conditions are warranted. We suggest a national registry to be installed in different countries in order to identify fragile X premutation carriers at increased risk for various medical complications.

Entities:  

Keywords:  Carrier; FMR1; FMRP; Fragile X; Premutation

Mesh:

Substances:

Year:  2016        PMID: 27312842     DOI: 10.1007/s12311-016-0804-y

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  16 in total

1.  Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.

Authors:  Faraz Farzin; Hazel Perry; David Hessl; Danuta Loesch; Jonathan Cohen; Susan Bacalman; Louise Gane; Flora Tassone; Paul Hagerman; Randi Hagerman
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

Review 2.  FXTAS: a progressive neurologic syndrome associated with Fragile X premutation.

Authors:  Rob Willemsen; Edwin Mientjes; Ben A Oostra
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

3.  Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010.

Authors: 
Journal:  MMWR Surveill Summ       Date:  2014-03-28

4.  Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype.

Authors:  Ching-Cherng Tzeng; Li-Ping Tsai; Wuh-Liang Hwu; Shio-Jean Lin; Mei-Chyn Chao; Yuh-Jyh Jong; Shao-Yin Chu; Wei-Chen Chao; Chin-Li Lu
Journal:  Am J Med Genet A       Date:  2005-02-15       Impact factor: 2.802

5.  Defining genetically meaningful language and personality traits in relatives of individuals with fragile X syndrome and relatives of individuals with autism.

Authors:  Molly Losh; Jessica Klusek; Gary E Martin; John Sideris; Morgan Parlier; Joseph Piven
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-06-12       Impact factor: 3.568

Review 6.  Fragile X and reproduction.

Authors:  J Ryan Martin; Aydin Arici
Journal:  Curr Opin Obstet Gynecol       Date:  2008-06       Impact factor: 1.927

7.  Examination of reproductive aging milestones among women who carry the FMR1 premutation.

Authors:  E G Allen; A K Sullivan; M Marcus; C Small; C Dominguez; M P Epstein; K Charen; W He; K C Taylor; S L Sherman
Journal:  Hum Reprod       Date:  2007-06-22       Impact factor: 6.918

8.  Impaired response inhibition is associated with self-reported symptoms of depression, anxiety, and ADHD in female FMR1 premutation carriers.

Authors:  Claudine M Kraan; Darren R Hocking; Nellie Georgiou-Karistianis; Sylvia A Metcalfe; Alison D Archibald; Joanne Fielding; Julian Trollor; John L Bradshaw; Jonathan Cohen; Kim M Cornish
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-10-26       Impact factor: 3.568

9.  FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States.

Authors:  Feras M Hantash; Dana M Goos; Beryl Crossley; Ben Anderson; Ke Zhang; Weimin Sun; Charles M Strom
Journal:  Genet Med       Date:  2011-01       Impact factor: 8.822

Review 10.  Associated features in females with an FMR1 premutation.

Authors:  Anne C Wheeler; Donald B Bailey; Elizabeth Berry-Kravis; Jan Greenberg; Molly Losh; Marsha Mailick; Montserrat Milà; John M Olichney; Laia Rodriguez-Revenga; Stephanie Sherman; Leann Smith; Scott Summers; Jin-Chen Yang; Randi Hagerman
Journal:  J Neurodev Disord       Date:  2014-07-30       Impact factor: 4.025

View more
  3 in total

1.  When the Ideal Meets the Feasible: Constructing a Protocol for Developmental Assessment at Early School-Age.

Authors:  Adel Farhi; Saralee Glasser; Shay Frank; Galit Hirsh-Yechezkel; Louise Brinton; Bert Scoccia; Rafael Ron-El; Liat Lerner-Geva; Lidia V Gabis
Journal:  Front Pediatr       Date:  2018-09-24       Impact factor: 3.418

2.  The prevalence of CGG repeat expansion mutation in FMR1 gene in the northern Chinese women of reproductive age.

Authors:  Yinan Ma; Xing Wei; Hong Pan; Songtao Wang; Xin Wang; Xiaowei Liu; Liying Zou; Xiaomei Wang; Xiaorong Wang; Hua Yang; Fengying Wang; Kefang Wang; Lifang Sun; Xiaolin Qiao; Yue Yang; Xiuhua Ma; Dandan Liu; Guifeng Ding; Junqi Ma; Xiuli Yang; Sainan Zhu; Yu Qi; Chenghong Yin
Journal:  BMC Med Genet       Date:  2019-05-16       Impact factor: 2.103

3.  Bisulfite Treatment of CG-Rich Track of Trinucleotide Repeat Expansion Disorder: Make the Sequence Less CG Rich.

Authors:  Zahra Joz Abbasalian; Hossein Khanahmad; Mohammad Amin Tabatabaiefar
Journal:  Adv Biomed Res       Date:  2021-12-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.